LICN

6-K - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen International Ltd (0001876766) (Filer)

EFFECT - Lichen International Ltd (0001876766) (Filer)

S-8 - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen International Ltd (0001876766) (Filer)

20-F - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen International Ltd (0001876766) (Filer)

6-K - Lichen China Ltd (0001876766) (Filer)

XIAMEN, China, Feb. 27, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced the date of effectiveness and the ratio of a forthcoming reverse stock split (the "Reverse Split") of the Company's ordinary shares (the "Ordinary Shares"). On February 12, 2025, the Company announced, on a Current Report on Form 6-K, the voting results from the annual meeting of shareholders (the "Meeting") held on February 10, 2025. At the Meeting, shareholders voted upon and approved Proposal 2 to effect a Reverse Split with a ratio of not less than one-for-twenty and not more than one-for-two-hundr

6-K - Lichen China Ltd (0001876766) (Filer)

6-K - Lichen China Ltd (0001876766) (Filer)

XIAMEN, China, Feb. 18, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying that the Company is not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule"), as the Company's securities had a closing bid price of $0.10 or less for eleven consecutive trading days from January 28, 2025 through February 11, 2025. The letter indicated that, as a result, the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delis

SCHEDULE 13G/A - Lichen China Ltd (0001876766) (Subject)

6-K - Lichen China Ltd (0001876766) (Filer)

6-K - Lichen China Ltd (0001876766) (Filer)

XIAMEN, China, Feb. 10, 2025 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China") (NASDAQ:LICN), a leading financial and taxation service provider in China, today announced the completion of its acquisition of the remaining 40% equity interest in Bondly Enterprises Limited ("Bondly"), a prominent domestic consulting firm specializing in business process management and informationization. This acquisition follows Lichen China's initial purchase of 60% equity in Bondly in 2024, and marks a significant step in Lichen China's strategy to fully integrate Bondly's advanced technologies and AI capabilities into its operations. The acquisition, valued at US$5,330,000, underscores

6-K - Lichen China Ltd (0001876766) (Filer)

6-K - Lichen China Ltd (0001876766) (Filer)

New York, New York, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the of registered direct offering (the "Offering") for its client Lichen China Limited (NASDAQ:LICN) (the "Company"), a dedicated financial and taxation service provider. Under the terms of the securities purchase agreement, the Company has agreed to sell to several investors for the purchase and sale of an aggregate of 42,500,000 shares of Company's Class A ordinary share, par value $0.00004 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchas

424B5 - Lichen China Ltd (0001876766) (Filer)

XIAMEN, China, Jan. 28, 2025 /PRNewswire/ -- Lichen China Limited (NASDAQ:LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 42,500,000 of the Company's Class A ordinary share, par value $0.00004 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $0.08 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share. The aggregate gross proceeds to the Company